Oxford University/AstraZeneca COVID-19 vaccine approved

Oxford University/AstraZeneca COVID-19 vaccine approved

January 4, 2021

The COVID-19 vaccine developed by Oxford University/AstraZeneca was yesterday given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA) after meeting required safety, quality and effectiveness standards.

Like many community pharmacists, PSNC is keen to see the sector able to play a greater role in the vaccination programme now the Oxford University/AZ vaccine can be used; we have clearly communicated that message to the Department of Health and Social Care and NHS England and NHS Improvement and will continue to do so.

Read more here




More Latest News >

PQS Part 2 – Thank You!

GMLPC are pleased to say that the large majority of GM contractors and pharmacy teams engaged with PQS Part 2...

GMLPC Election 2021 Results 

In accordance with the LPC constitution, Greater Manchester LPC organised an election to establish a new Committee From 1st April...

PSNC CEO February Blog

In his February blog, PSNC’s CEO Simon Dukes talks about the wide range of community pharmacy services, calling for the...

GMHCA Upcoming Training Opportunities

10:30am-12:30pm, Wednesday 10th March – ‘Women and Cancer (Health Awareness, Screening, and Prevention)’ hosted by Answer Cancer. Answer Cancer will...

Covid-19: Myth-busting Resources

Please see below for some useful resources that address myths surrounding Covid-19 and the vaccination. Joint Committee on Vaccination and...